What Researchers Did
Researchers compared late radiation changes in 15 patients treated for oral cavity or oropharynx carcinoma with continuous hyperfractionated accelerated radiotherapy (CHART) to 15 similar patients treated with conventional radiotherapy.
What They Found
Late changes in skin and mucosa were similar between CHART and conventional radiotherapy, but hair regrowth was observed in 6 out of 10 men treated with CHART compared to persistent hair loss in all 9 men receiving conventional therapy. After CHART, there was also a trend towards less taste impairment and less severe dryness of mouth.
What This Means for Canadian Patients
For Canadian patients undergoing radiotherapy for oral cavity or oropharynx cancer, CHART may offer improved quality of life outcomes, particularly regarding hair regrowth and potentially reduced taste impairment and dry mouth. These findings could inform treatment decisions aimed at minimizing long-term side effects.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The study involved a small sample size of 15 patients per main treatment group, which may limit the generalizability of the findings.